An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors

Pierre Maison-Blanche*, Shaker Dakhil, Ari Baron, Sylvie Rottey, Fred Millard, Gedske Daugaard, Jean-Pascal Machiels, William Conkright, Sunil Sharma, Patricia M. M. B. Soetekouw, Jeffrey Yachnin, Lisa Sengelov, Peter Van Veldhuizen, Sanjiv S. Agarwala, Dorothee Semiond, Mustapha Chadjaa, Liji Shen, James L. Wade

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1241-1252
JournalCancer Chemotherapy and Pharmacology
Issue number6
Publication statusPublished - Jun 2014


  • Cabazitaxel
  • QTc interval
  • Cardiac safety
  • Advanced solid tumors
  • Pharmacokinetics
  • ECG

Cite this